<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Bastola T</submitter><funding>NEI NIH HHS</funding><pubmed_abstract>Glaucoma is a leading cause of irreversible blindness, characterized by progressive retinal ganglion cell (RGC) loss and optic nerve degeneration. Mitochondrial dysfunction plays a central role in this neurodegeneration, yet effective targeted therapies remain limited. Here, we identify the mitochondrial scaffold A-kinase anchoring protein 1 (AKAP1) as a critical regulator of RGC resilience and axon regeneration. AKAP1 expression is diminished in human glaucomatous retinas and experimental glaucoma models, correlating with elevated intraocular pressure, disrupted mitochondrial dynamics, oxidative stress, and synaptic instability. Restoration of AKAP1 via adeno-associated virus serotype 2-mediated gene therapy preserves RGC survival, promotes mitochondrial fusion and cristae integrity, enha</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2025.11.24.689866</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12676536</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>AKAP1 regulates mitochondrial and synaptic homeostasis to enable neuroprotection and repair in retinal ganglion cell degeneration.</pubmed_title><pmcid>PMC12676536</pmcid><funding_grant_id>R01 EY034116</funding_grant_id><funding_grant_id>R01 EY031697</funding_grant_id><funding_grant_id>P30 EY022589</funding_grant_id><pubmed_authors>Ellisman MH</pubmed_authors><pubmed_authors>Ju WK</pubmed_authors><pubmed_authors>Weinreb RN</pubmed_authors><pubmed_authors>Gomez V</pubmed_authors><pubmed_authors>Choi H</pubmed_authors><pubmed_authors>Lim Y</pubmed_authors><pubmed_authors>Kim KY</pubmed_authors><pubmed_authors>Poudel M</pubmed_authors><pubmed_authors>Shen Z</pubmed_authors><pubmed_authors>Choi SH</pubmed_authors><pubmed_authors>Perkins GA</pubmed_authors><pubmed_authors>Bastola T</pubmed_authors><pubmed_authors>Won JY</pubmed_authors></additional><is_claimable>false</is_claimable><name>AKAP1 regulates mitochondrial and synaptic homeostasis to enable neuroprotection and repair in retinal ganglion cell degeneration.</name><description>Glaucoma is a leading cause of irreversible blindness, characterized by progressive retinal ganglion cell (RGC) loss and optic nerve degeneration. Mitochondrial dysfunction plays a central role in this neurodegeneration, yet effective targeted therapies remain limited. Here, we identify the mitochondrial scaffold A-kinase anchoring protein 1 (AKAP1) as a critical regulator of RGC resilience and axon regeneration. AKAP1 expression is diminished in human glaucomatous retinas and experimental glaucoma models, correlating with elevated intraocular pressure, disrupted mitochondrial dynamics, oxidative stress, and synaptic instability. Restoration of AKAP1 via adeno-associated virus serotype 2-mediated gene therapy preserves RGC survival, promotes mitochondrial fusion and cristae integrity, enha</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-04T03:21:22.936Z</modification><creation>2026-06-04T03:12:41.892Z</creation></dates><accession>S-EPMC12676536</accession><cross_references><pubmed>41357987</pubmed><doi>10.1101/2025.11.24.689866</doi></cross_references></HashMap>